Anavex Life Sciences Corp (AVXL)

[XenaLives]

Not me - Once the final Criteria is set I believe the Aussies will impliment it more quickly because of the the data they routinely collect for their National Medicare System. If the AU trial is large enough it is early readout there that could trigger approval.

Another possibility - Aussie patients used for the P2b part while U.S. patients come in at a later stage after a slower U.S. system puts its group of particpants into the trial.

Too many possibilities here to say when the approval process is in such a state of flux. Earlier this year I believed that the government was capable of putting the Alzheimer's healthcare crisis ahead of politics but it seems that is not the case.